Your browser doesn't support javascript.
loading
Accuracy of digital chest x-ray analysis with artificial intelligence software as a triage and screening tool in hospitalized patients being evaluated for tuberculosis in Lima, Peru.
Biewer, Amanda M; Tzelios, Christine; Tintaya, Karen; Roman, Betsabe; Hurwitz, Shelley; Yuen, Courtney M; Mitnick, Carole D; Nardell, Edward; Lecca, Leonid; Tierney, Dylan B; Nathavitharana, Ruvandhi R.
Afiliação
  • Biewer AM; Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Tzelios C; Harvard Medical School, Boston, Massachusetts, United States of America.
  • Tintaya K; Socios en Salud, Lima, Peru.
  • Roman B; Socios en Salud, Lima, Peru.
  • Hurwitz S; Harvard Medical School, Boston, Massachusetts, United States of America.
  • Yuen CM; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Mitnick CD; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Nardell E; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Lecca L; Socios en Salud, Lima, Peru.
  • Tierney DB; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Nathavitharana RR; Massachusetts Department of Public Health, Boston, Massachusetts, United States of America.
PLOS Glob Public Health ; 4(2): e0002031, 2024.
Article em En | MEDLINE | ID: mdl-38324610
ABSTRACT
Tuberculosis (TB) transmission in healthcare facilities is common in high-incidence countries. Yet, the optimal approach for identifying inpatients who may have TB is unclear. We evaluated the diagnostic accuracy of qXR (Qure.ai, India) computer-aided detection (CAD) software versions 3.0 and 4.0 (v3 and v4) as a triage and screening tool within the FAST (Find cases Actively, Separate safely, and Treat effectively) transmission control strategy. We prospectively enrolled two cohorts of patients admitted to a tertiary hospital in Lima, Peru one group had cough or TB risk factors (triage) and the other did not report cough or TB risk factors (screening). We evaluated the sensitivity and specificity of qXR for the diagnosis of pulmonary TB using culture and Xpert as primary and secondary reference standards, including stratified analyses based on risk factors. In the triage cohort (n = 387), qXR v4 sensitivity was 0.91 (59/65, 95% CI 0.81-0.97) and specificity was 0.32 (103/322, 95% CI 0.27-0.37) using culture as reference standard. There was no difference in the area under the receiver-operating-characteristic curve (AUC) between qXR v3 and qXR v4 with either a culture or Xpert reference standard. In the screening cohort (n = 191), only one patient had a positive Xpert result, but specificity in this cohort was high (>90%). A high prevalence of radiographic lung abnormalities, most notably opacities (81%), consolidation (62%), or nodules (58%), was detected by qXR on digital CXR images from the triage cohort. qXR had high sensitivity but low specificity as a triage in hospitalized patients with cough or TB risk factors. Screening patients without cough or risk factors in this setting had a low diagnostic yield. These findings further support the need for population and setting-specific thresholds for CAD programs.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article